Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04327141Not ApplicableActive Not Recruiting

Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women

Role: collaborator

NCT04763473Not ApplicableCompleted

AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)

Role: collaborator

NCT03850275Not ApplicableCompleted

The Effects of e+Shots Energy Beverage on Mental Energy

Role: collaborator

NCT03371966Not ApplicableCompleted

Nitrate and Exercise Performance in Middle to Older Aged Adults

Role: collaborator

NCT02529605Not ApplicableCompleted

Relative Bioavailability of Two Different Milk Thistle Formulations

Role: collaborator

NCT02525419Not ApplicableCompleted

Intermittent Fasting, Caloric Restriction and Body Composition in Obese Men and Women

Role: collaborator

All 6 trials loaded